Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

Nav

General Info

Geography

Argentina (ARG)

Belgium (BEL)

Brazil (BRA)

Canada (CAN)

Czechia (CZE)

Denmark (DNK)

Finland (FIN)

Germany (DEU)

Hungary (HUN)

Iceland (ISL)

Mexico (MEX)

Netherlands (NLD)

Norway (NOR)

Poland (POL)

Sweden (SWE)

Switzerland (CHE)

United Kingdom (GBR)

United States of America (USA)

View all

Time period covered

01/1997 - 12/1998

Data type

Scientific literature

Keywords

Cardiovascular and circulatory diseases, Ischemic heart disease, Stroke

Citation

Authors

Heart Outcomes Prevention Evaluation Study Investigators, Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G

Journal

N Engl J Med

Volume

342

Issue

Pages

145–53

Publication year

2000

Suggested citation

Heart Outcomes Prevention Evaluation Study Investigators, Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000; 342(3): 145–53.

GHDx Entry last modified on: Oct 25, 2024

Header sites

Search form

Main menu

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

Nav